Enovis Flourishes in First Year as Stand-Alone
Enovis reported 4Q22 orthopedic sales of $162.5 million, +10.4% compared to 4Q21. Including contributions from acquisitions, the company generated $599.4... Feb 27, 2023
Medtronic’s Arsenal of Technology Driving Growth
The company's reported orthopedic sales grew by low-single digits during the third quarter of its 2023 fiscal year. Feb 27, 2023
3 Market Trends in Joint Replacement
New technologies, increasing cementless adoption and volume-based procurement in China set the stage for a dynamic year in joint replacement. Feb 24, 2023
NuVasive’s Cervical and International Sales Drive 2022 Growth
The company exited 2022 with mid-single digit growth despite macro headwinds, driven by its C360 portfolio and international sales. Feb 24, 2023
Globus Crossed $1 Billion Threshold in 2022
The company exceeded $1 billion in annual sales for the first time in 2022, representing high-single digit growth compared to 2021. Feb 23, 2023
Smith+Nephew Exits 2022 With Improved Execution
The company exited 2022 with early momentum in its plan to revitalize its orthopedics franchise and improve execution. Feb 22, 2023
Making Sense of Globus Medical’s Deal for NuVasive
The company's pending acquisition of NuVasive is about increasing operational capacity and vertical integration. Feb 15, 2023
Globus Medical to Acquire NuVasive for $3.1 Billion
The combines will combine in an all-stock merger to create the 7th largest orthopedic company overall and 2nd largest spine player. Feb 09, 2023
CONMED Suffers Self-Inflicted Wound to End 2022
The company's organic orthopedic sales declined slightly in 2022 as a faulty software implementation hampered 4Q sales. Feb 07, 2023
Zimmer Biomet’s Priority Markets Drove 2022 Growth
The company grew in the mid-single digits for 2022 when excluding the impact of foreign currency translation. Feb 06, 2023
